Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomaterials entrepreneurship.

J R Ellis1

  • 1Jeffrey R. Ellis, Inc., Technical & Economic Services, Newtown, PA 18940.

Journal of Biomaterials Applications
|January 1, 1988
PubMed
Summary
This summary is machine-generated.

Biomaterials entrepreneurs face unique challenges in developing innovative medical devices, requiring significant time for safety testing and commercialization. Despite hurdles, successful ventures attract major healthcare partners, driving advancements in areas like artificial blood vessels and prosthetics.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Highly Ionizing Particles in pp Collisions during LHC Run 2 Using the Full MoEDAL Detector.

Physical review letters·2025
Same author

Erratum: First Search for Dyons with the Full MoEDAL Trapping Detector in 13 TeV pp Collisions [Phys. Rev. Lett. 126, 071801 (2021)].

Physical review letters·2024
Same author

MoEDAL Search in the CMS Beam Pipe for Magnetic Monopoles Produced via the Schwinger Effect.

Physical review letters·2024
Same author

Search for magnetic monopoles produced via the Schwinger mechanism.

Nature·2022
Same author

First Search for Dyons with the Full MoEDAL Trapping Detector in 13 TeV pp Collisions.

Physical review letters·2021
Same author

Magnetic Monopole Search with the Full MoEDAL Trapping Detector in 13 TeV pp Collisions Interpreted in Photon-Fusion and Drell-Yan Production.

Physical review letters·2019
Same journal

Effect of alloying and adding hydroxyapatite on the mechanical and corrosive properties of porous magnesium (Mg).

Journal of biomaterials applications·2026
Same journal

From leaf to cellulose scaffold: Decellularization and multi-scale characterization of <i>Neolamarckia cadamba</i> leaf for biomedical applications.

Journal of biomaterials applications·2026
Same journal

Gelatin-based cryogels seeded with exosomes enhance osteogenic activity and bone regeneration in a rabbit femoral defect model.

Journal of biomaterials applications·2026
Same journal

Carbon monoxide-releasing molecule-3 eradicates mature <i>Enterococcus faecalis</i> biofilms and inhibits recolonization.

Journal of biomaterials applications·2026
Same journal

Natural melanin nanoparticles modified with glycol chitosan for enhanced delivery of oxaliplatin.

Journal of biomaterials applications·2026
Same journal

Epidural thickness of the dura sealants HEMOPATCH® and TACHOSIL® after elective supratentorial craniotomy: A comparative retrospective monocentric cohort study.

Journal of biomaterials applications·2026
See all related articles

Area of Science:

  • Biomaterials Science
  • Medical Device Development
  • Entrepreneurship

Background:

  • Established healthcare companies face challenges in direct new product development due to liability and conservatism.
  • Biomaterials entrepreneurs play a crucial role in mitigating risks associated with novel product and device innovation.

Purpose of the Study:

  • To highlight the difficulties and timelines associated with commercializing biomaterials into medical devices.
  • To identify key funding sources and potential exit strategies for biomaterials startups.
  • To outline current unmet needs in biomaterials and device design.

Main Methods:

  • The abstract discusses the entrepreneurial journey in biomaterials, focusing on challenges, funding, and market needs.
  • It outlines the extended timelines for safety and toxicity testing (3-5+ years).

Related Experiment Videos

  • It identifies specific device needs, such as small-diameter artificial blood vessels and advanced prosthetic components.

    • Main Results:

    • Biomaterials entrepreneurs face greater commercialization difficulties than those in other fields.
    • Achieving profitability requires converting biomaterials into functional devices, a process demanding significant time and investment.
    • Successful initial ventures can attract major healthcare corporations.

    Conclusions:

    • The development of biomaterials into viable medical devices is a lengthy and capital-intensive process.
    • There is a clear demand for biomaterials that offer improved tissue compatibility and durability for internal prosthetic applications.
    • Continued innovation in biomaterials is essential for addressing critical needs in cardiovascular and orthopedic medical devices.